Literature DB >> 20236734

A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.

Svetoslav H Slavov1, Maksim Radzvilovits, Susan LeFrancois, Iva B Stoyanova-Slavova, Ferenc Soti, William R Kem, Alan R Katritzky.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) have become targets for drug development in recent years. 3-(2,4-dimethoxybenzylidene)-anabaseine (DMXBA), which selectively stimulates the alpha7 nAChR, has been shown to alleviate some cognitive deficits associated with schizophrenia. In this paper we report an analysis of the interactions between 47 arylidene-anabaseines (including 45 benzylidene-anabaseines) and rat brain alpha7 and alpha4beta2 nicotinic acetylcholine receptors, using three different modeling techniques, namely 2D-QSAR, 3D-QSAR and molecular docking to the Aplysia californica acetylcholine binding protein (AChBP), a water soluble, homomeric nAChR surrogate receptor with a known crystal structure. Our investigation indicates the importance of: (1) the nitrogen atom of the tetrahydropyridyl (THP) ring for hydrogen bond formation; (2) pi-pi interactions between the aromatic rings of the ligands and the nAChBP binding site; (3) molecular surface recognition expressed in terms of steric complimentarity. On the basis of the 3D-QSAR results, bulky substituents at positions 2 (and due to the rotational freedom also at position 6) and 4 of the benzylidene moiety, with highly electronegative atoms projecting approximately 3-3.5A away from the benzylidene ring at position 4 seem optimal for enhancing binding affinity to the alpha7 nAChR. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236734     DOI: 10.1016/j.ejmech.2010.02.027

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.

Authors:  David C Kombo; Anatoly Mazurov; Kartik Tallapragada; Philip S Hammond; Joseph Chewning; Terry A Hauser; Montserrat Vasquez-Valdivieso; Daniel Yohannes; Todd T Talley; Palmer Taylor; William S Caldwell
Journal:  Eur J Med Chem       Date:  2011-09-29       Impact factor: 6.514

2.  The twin drug approach for novel nicotinic acetylcholine receptor ligands.

Authors:  Isabelle Tomassoli; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2015-06-20       Impact factor: 3.641

3.  Point-to-point ligand-receptor interactions across the subunit interface modulate the induction and stabilization of conformational states of alpha7 nAChR by benzylidene anabaseines.

Authors:  Matthew D Isaacson; Nicole A Horenstein; Clare Stokes; William R Kem; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2013-01-23       Impact factor: 5.858

4.  Investigation of the Possible Pharmacologically Active Forms of the Nicotinic Acetylcholine Receptor Agonist Anabaseine.

Authors:  Kristin Andrud; Hong Xing; Bjarne Gabrielsen; Linda Bloom; Vladimir Mahnir; Stephen Lee; Benedict T Green; Jon Lindstrom; William Kem
Journal:  Mar Drugs       Date:  2019-10-29       Impact factor: 5.118

Review 5.  Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease.

Authors:  Márcia Martins; Renata Silva; Madalena M M Pinto; Emília Sousa
Journal:  Pharmaceuticals (Basel)       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.